InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2025-06-02 00:00:00 ET · period of report 2025-06-01 · accession 0001576280-25-000159 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-02 2025-06-01 GH Kalia Kumud CIO M - OptEx $0.00 +710 23.0K +3% $0
D 2025-06-02 2025-06-01 GH Kalia Kumud CIO F - Tax $40.62 -254 22.8K -1% -$10.3K
D 2025-06-02 2025-06-01 GH Kalia Kumud CIO M - OptEx $0.00 -710 711 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-01 M A 710 $0.00 23,019 D — —
2 Common Common Stock 2025-06-01 F D 254 $40.62 22,765 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
3 Derivative Restricted Stock Units 2025-06-01 M D 710 $0.00 711 D $0.00 · — to — 710 Common Stock (F2) The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. (F3) Not applicable for Restricted Stock Units.